| RASSF2 is a novel tumor suppressor gene that regulates Ras signaling and plays a pivotal role in the early stages of colorectal tumorigenesis. | colorectal, |
| The epigenetic silencing of tumor suppressor genes involved in the Ras/PI3K/AKT pathway plays an important role in oral squamous cell carcinoma radioresistance | oral |
| Results suggest that RASSF2 encodes a novel epigenetically inactivated candidate tumor suppressor gene in thyroid carcinogenesis. | thyroid, |
| results suggest that both RASSF1A and RASSF2 are novel epigenetically inactivated tumor suppressor genes in Ewing sarcoma and RASSF2 methylation may have prognostic implications for ES patients | sarcoma, |
| The microRNA-200 family acts as an oncogene in colorectal cancer by inhibiting the tumor suppressor RASSF2 | colorectal, |
| RASSF2 is a new member of the RASSF1 family of Ras effectors/tumor suppressors that exhibits a specificity for interacting with K-Ras | None |
| Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals. | None |
| The K-Ras-specific effector and potential tumor suppressor gene RASSF2 contains a breed-specific expressed tranversion polymorphism as confirmed in day 25 Meishan and white composite swine placentae. | None |
| Extracellular signal-regulated kinase 2 (ERK-2) mediated phosphorylation regulates nucleo-cytoplasmic shuttling and cell growth control of Ras-associated tumor suppressor protein, RASSF2. | None |
| Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity. | None |
| our results suggest that RASSF2 may function as a tumor suppressor gene | None |